テキサスにおける直腸がんの臨床試験
テキサス内の拠点で、直腸がんに関する18件の研究が参加者を募集しています。
テキサス内の都市
公式研究テキスト（英語）
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Texas Oncology - DFW ( Site 8002), Dallas
- UT Southwestern Medical Center ( Site 0059), Dallas
- Texas Oncology - Northeast Texas ( Site 8001), Denison
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06997497Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- MD Anderson, Houston
- NEXT Dallas, Irving
- NEXT Oncology San Antonio, San Antonio
- 他1件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/21更新 · NCT07629960ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- UT Southwestern Medical Center, Dallas
- DHR Health Advance Care Center, Edinburg
- The Center for Cancer and Blood Disorders, Forth Worth
- 他1件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Audie L Murphy VA Hospital, San Antonio
被験者募集中
45歳〜70歳 · 全性別 · 2026/09/02更新 · NCT05080673Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
- University of Texas Health Science Center at Houston, Houston
被験者募集中
18歳以上 · 全性別 · 2026/09/01更新 · NCT07351071Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer
- M D Anderson Cancer Center, Houston
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/31更新 · NCT02107105Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With/Without BMX-001
- UT Health San Antonio MD Anderson Cancer Center, San Antonio
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/20更新 · NCT05254327Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
- UT MD Anderson Cancer Center, Houston
- Scott and White Memorial Hospital, Temple
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/14更新 · NCT06205485Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery
- UT Southwestern Medical Center, Dallas
被験者募集中第2/3相
18歳〜80歳 · 全性別 · 2026/06/30更新 · NCT03051464A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- The University of Texas MD Anderson Cancer Center, Houston
- NEXT Oncology, San Antonio
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/29更新 · NCT07458347A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
- Texas Oncology - Central/South Texas, Austin
- Texas Oncology - Gulf Coast, Beaumont
- Texas Oncology - Northeast Texas, Tyler
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/12更新 · NCT07011576Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer
- M D Anderson Cancer Center, Houston
被験者募集中早期第1相
18歳以上 · 全性別 · 2026/05/20更新 · NCT03594630Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- MD Anderson Cancer Center, Houston
- NEXT Oncology, San Antonio
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/06更新 · NCT06239194Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Therapy
- MD Anderson Cancer Center, Houston
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/16更新 · NCT06569368The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Md Anderson Cancer Center, Houston
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/05更新 · NCT04075305Sample Collection for Ongoing Research and Product Evaluation Study
- Natera, Inc., Austin
被験者募集中観察研究
18歳以上 · 全性別 · 2026/01/15更新 · NCT07318051SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Dallas
- Massive Bio SYNERGY-AI site, Houston
- Massive Bio SYNERGY-AI site, Temple
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。